Pharma Marketing News Vol. 7, #10

Welcome to the December, 2008 issue of Pharma Marketing News.

Use of Celebrities for PR and DTC Advertising

If you have questions about the 'dos & don'ts' and 'pros & cons' of using medical and non-medical mouthpieces for pharma PR and DTC advertising, this article provides some answers and opinions based on interviews of experts with years of experience in this area.

Pharma Marketing News Vol. 7, #8

Welcome to the October, 2008 issue of Pharma Marketing News.

Wither CME?

Congress continues to examine pharma industry support of CME and ACCME has issued some new guidance for accredited CME providers. This article examines the current state of industry support for CME and what reforms may be coming down the pike.

Pharma Marketing News Vol. 7, #1

Vol. 7, No. 1: January 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!...

Understanding the Strategic Value of MSLs

This article examines how tomorrow's MSL might be employed by Pharma and discusses the strategic movement of MSLs into the competitive intelligence space, teaching roles, strategic input to and evaluation of portfolio development, and investor relations.

Moving the Needle on Adherence

Both the financial and social implications of non-compliance were the subjects of the recent 7th Annual Forum on Patient Compliance, Adherence and Persistency. This article presents highlights and case studies from this forum.

Pharma Marketing News Vol. 7, #9

Welcome to the November, 2008 issue of Pharma Marketing News.

Pharma Marketing News Vol. 7, #4

Vol. 7, No. 4: April 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!...

Reforming the FDA

Possibly the most important political change facing the pharmaceutical industry in 2006 is who will be the new FDA Commissioner. Various stakeholders -- including executives and staffers working within the pharmaceutical industry, agents and vendors to the industry, healthcare professionals, members of the general public, and staffers within government health agencies -- have divergent opinions on who should be the commissioner and why. This article summarizes the results of a recent survey of such stakeholders.

STAY CONNECTED

30,126FollowersFollow
- Advertisement -